Crystalvue Medical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	949.05	868.03	823.96	795.46	721.61
Revenue Growth (YoY)	9.33%	5.35%	3.58%	10.23%	43.07%
Cost of Revenue	617.17	568.89	557.22	533.71	510.22
Gross Profit	331.88	299.14	266.75	261.74	211.39
Selling, General & Admin	110.68	108.48	104.4	89.97	73.73
Research & Development	40.25	45.66	44.67	46.97	49.2
Operating Expenses	150.93	154.14	149.07	136.94	122.93
Operating Income	180.95	145.01	117.68	124.8	88.47
Interest Expense	-0.45	-0.63	-0.82	-1	-1.17
Interest & Investment Income	2.23	2.14	1.47	0.47	1.06
Currency Exchange Gain (Loss)	-	6.33	1.19	10.68	-2.11
Other Non Operating Income (Expenses)	-3.71	6.53	0.22	7.48	8.97
EBT Excluding Unusual Items	179.01	159.38	119.74	142.44	95.22
Gain (Loss) on Sale of Assets	-	-	-	-	13.95
Pretax Income	179.01	159.38	119.74	142.44	109.17
Income Tax Expense	32.03	32.23	16.34	27.41	31.93
Net Income	146.98	127.15	103.4	115.03	77.24
Net Income to Common	146.98	127.15	103.4	115.03	77.24
Net Income Growth	15.59%	22.98%	-10.11%	48.93%	36.42%
Shares Outstanding (Basic)	25	25	25	25	25
Shares Outstanding (Diluted)	26	26	25	26	25
Shares Change (YoY)	0.38%	1.64%	-0.91%	0.53%	-0.99%
EPS (Basic)	5.80	5.02	4.13	4.59	3.08
EPS (Diluted)	5.70	4.95	4.09	4.51	3.05
EPS Growth	15.15%	21.03%	-9.31%	47.98%	37.93%
Free Cash Flow	-44.98	22.62	149.64	44.24	-287.91
Free Cash Flow Per Share	-1.74	0.88	5.92	1.73	-11.35
Dividend Per Share	-	2.250	2.070	2.286	1.848
Dividend Growth	-	8.70%	-9.44%	23.71%	38.57%
Gross Margin	34.97%	34.46%	32.37%	32.91%	29.29%
Operating Margin	19.07%	16.71%	14.28%	15.69%	12.26%
Profit Margin	15.49%	14.65%	12.55%	14.46%	10.70%
Free Cash Flow Margin	-4.74%	2.61%	18.16%	5.56%	-39.90%
EBITDA	198.76	165.75	139.51	143.92	122.55
EBITDA Margin	20.94%	19.10%	16.93%	18.09%	16.98%
D&A For EBITDA	17.82	20.75	21.83	19.11	34.09
EBIT	180.95	145.01	117.68	124.8	88.47
EBIT Margin	19.07%	16.71%	14.28%	15.69%	12.26%
Effective Tax Rate	17.89%	20.22%	13.65%	19.25%	29.25%
Advertising Expenses	-	-	-	-	26.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.